Nature | August 12, 2026
“The thing that doesn’t fit for me is the fact that the effects seem relatively immediate,” says Jeff Iliff, PhD. “I have a hard time understanding how those kinetics work.”
Nature | August 12, 2026
“The thing that doesn’t fit for me is the fact that the effects seem relatively immediate,” says Jeff Iliff, PhD. “I have a hard time understanding how those kinetics work.”
The Washington Post | August 11, 2026
The benefits of CBD are particularly attractive for people with chronic pain who need a way to constantly manage their problems without getting high, said Nephi Stella, PhD.
The Seattle Times | August 11, 2026
“There’s a level of complicity that society owns, where we make this country a place where guns are so widely available,” said Ben Danielson, MD.
Right as Rain | July 29, 2026
“When we’re brave, it’s an opportunity for us to free ourselves of our shame and maybe even get some help,” says Katherine Seldin, PhD.
UW Medicine Newsroom | July 29, 2026
“We want to move the field forward in generating therapeutics toward xylazine. This is the first step toward that,” said Jason Kang, PhD.
UW Medicine Newsroom | July 22, 2026
There's a lot that can happen after first treatment, said Jessica Acolin, PhD, like quality of care and continued follow-up, that matter for long-term survival.
UW News | July 22, 2026
A new institute co-led by Marco Pravetoni, PhD brings together experts to ease the bottleneck between promising molecules and successful drugs.
Right as Rain | July 20, 2026
Sleep tracking can be a double-edge sword, says Jeff Iliff, PhD. If trackers say your sleep isn't good, that can be a source of anxiety and lead to insomnia.
Psychiatric Times | July 9, 2026
Katharine Liang, MD, PhD joins the "Psychopharm Today" video-podcast, a series in which ASCP memebers converse about the latest hot topics in psychopharmacology.
New York Times | July 9, 2026
Margaret Sibley, PhD believes that aggressive advertisements may have contributed to the rising rates of ADHD diagnosis among adults.